·
3 Min Read

Removing prior authorization for MAT results in more patient care

Learn how Maryland has changed the law to help patients with opioid-use disorder get the evidence-based care they need.

Prior Authorization
·
7 Min Read

Jan. 30, 2020: National Advocacy Update

Surgeon General & smoking cessation report, value-based care regulatory changes and more in the latest AMA national health care advocacy news.

Advocacy Update
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of Jan. 20, 2020

In the news: ICU deaths higher for minorities, sunscreen absorbed into blood, Coronavirus, Surgeon General on smoking, new bills prevent treating transgender teens.

Publications & Newsletters
Rachel Franklin, MD
·
3 Min Read

Reforming pain-management education for the next generation of physicians

Rachel Franklin, MD, starts from the ground up to create an objectively assessed, mechanism-based management program for chronic pain.

ChangeMedEd Initiative
·
7 Min Read

Jan. 17, 2020: National Advocacy Update

CDC opioid prescribing guidelines, MIPS eligible clinicians and more in the latest AMA national health care advocacy news.

Advocacy Update
·
4 Min Read

July 13, 2017: National Advocacy Update

AMA urges modifications in opioid prescriber education blueprint; New update provides better Quality Payment Program reporting; Many physicians, still fuzzy on details, feel unprepared for QPP

Advocacy Update
·
3 Min Read

Prior authorization of nonopioid pain care prolongs patient suffering

A 10-day trial yields instant pain relief for a patient, but it takes several months to obtain an insurer’s OK for the treatment.

Prior Authorization
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of Dec. 30, 2019

In the news: HPV vaccines, organic pollutants effect on fetal growth, e-cig flavor ban, veterans’ health and pyrethroids association with cardiovascular risks.

Publications & Newsletters
Man using e-cigarette
·
3 Min Read

Vaping: Move to ban some flavors only 1st step in addiction fight

Juul and similar companies can continue to sell menthol-flavored cartridges while open-system flavored e-liquids will remain easy to access. Learn about what should happen next.

Behavioral Health